A Novel Method for Signaling Pathway Analysis

Information

  • Research Project
  • 7612527
  • ApplicationId
    7612527
  • Core Project Number
    R41GM087013
  • Full Project Number
    1R41GM087013-01
  • Serial Number
    87013
  • FOA Number
    PAR-07-161
  • Sub Project Id
  • Project Start Date
    3/1/2009 - 15 years ago
  • Project End Date
    8/31/2010 - 14 years ago
  • Program Officer Name
    LYSTER, PETER
  • Budget Start Date
    3/1/2009 - 15 years ago
  • Budget End Date
    8/31/2010 - 14 years ago
  • Fiscal Year
    2009
  • Support Year
    1
  • Suffix
  • Award Notice Date
    2/27/2009 - 16 years ago
Organizations

A Novel Method for Signaling Pathway Analysis

DESCRIPTION (provided by applicant): A common challenge in the analysis of genomics data is trying to understand the underlying phenomenon in the context of all complex interactions on various regulatory pathways. Currently, a statistical approach is universally used to identify the most relevant pathways in a given experiment. This approach only considers the set of genes present on each pathway and completely ignores other important biological factors. Here we show that in spite of its general adoption, and independently of the particular model used, this statistical analysis is unsatisfactory, and can often provide incorrect results. Using a systems biology approach, we developed an impact analysis that includes the classical statistics, but also considers other crucial factors such as the magnitude of each gene's expression change, their type and position in the given pathways, their interactions, etc. Our preliminary work shows that the classical analysis produces both false positives and false negatives while the impact analysis provides biologically meaningful results. In this Phase I application, we are proposing to develop a prototype that would demonstrate the feasibility of a commercial software analysis package based on this novel approach. Our team has a very strong track record as demonstrated by: a large number of citations to our previous publications, a large user-base for our previously developed software (over 5,000 scientists from all 5 continents), and very strong letters of support. 1 PUBLIC HEALTH RELEVANCE: The classical statistical approaches, which are universally used to identify the most relevant biological pathways in a given experiment, only consider the number of di(R)erentially expressed genes on each pathway and completely ignores other important biological factors. However, in spite of its general adoption, these statistical approaches are unsatisfactory, and can often provide incorrect results. We propose a novel signaling pathway analysis that includes the classical statistics, but also considers other crucial factors such as the magnitude of each gene's expression change, their type and position in the given pathways, their interactions, etc.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R41
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    146256
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:146256\
  • Funding Mechanism
    SBIR-STTR
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ADVAITA CORPORATION
  • Organization Department
  • Organization DUNS
    198047529
  • Organization City
    PLYMOUTH
  • Organization State
    MI
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    481702424
  • Organization District
    UNITED STATES